The FDA’s authorisation of Medtronic’s BrainSense follows the system’s receipt of a CE mark in Europe last month.

Medtronic (NYSE:MDT) has won FDA approval for a deep brain stimulation system for Parkinson’s disease. The approval is for ...

Shortly after obtaining a greenlight in Europe and after more than 10 years in development, Medtronic has now received the ...

To combat a severe mental health crisis in the US, researchers invented a groundbreaking new method to reach deep brain ...

Researchers from Carnegie Mellon University and Allegheny Health Network have developed a new method for deep brain ...

Medtronic said the Food and Drug Administration approved a brain stimulation system for people afflicted with Parkinson's disease.

Carnegie Mellon researchers developed "DeepFocus," a new method for brain stimulation that combines transnasal and transcranial electrical stimulation for minimally invasive targeting of deep brain ...

Deep brain stimulation is a medical procedure where electrodes are placed in certain target areas of the brain to treat ...

In the third episode of The Deep End, Jon shares how DBS surgery went and how he and other volunteers felt in the days and weeks afterward.

With the platform HoloSNS — created by Professor of Biomedical Engineering Cameron McIntyre and his team — physicians and ...

BrainSense Adaptive deep brain stimulation (aDBS) and BrainSense Electrode Identifier (EI) for patients with Parkinson’s ...

Medtronic (MDT) announced FDA approval of BrainSense Adaptive deep brain stimulation – aDBS – and BrainSense Electrode Identifier. There is no ...